On Monday, DexCom Inc (DXCM) stock saw a decline, ending the day at $87.53 which represents a decrease of $-1.22 or -1.37% from the prior close of $88.75. The stock opened at $88.58 and touched a low ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

Shares of DexCom Inc. DXCM slid 1.37% to $87.53 Monday, on what proved to be an all-around mixed trading session for the ...

Fifth Third Bancorp grew its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...

DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $88.75 which represents a slight increase of $1.05 or 1.20% from the prior close of $87.7. The stock opened at $88 and touched a low of ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...

Dexcom bet on the high financial ceiling that exists by integrating its glucose monitoring capabilities into the ring, ...

This was the stock's fourth consecutive day of gains.

Baird has upgraded DexCom (DXCM) to outperform, citing increasing confidence in the company's ability to return revenue ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...